112 related articles for article (PubMed ID: 2194646)
1. S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling.
Nemoto R; Hattori K; Uchida K; Shimazui T; Nishijima Y; Koiso K; Harada M
Cancer; 1990 Aug; 66(3):509-14. PubMed ID: 2194646
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma.
Nemoto R; Uchida K; Shimazui T; Hattori K; Koiso K; Harada M
J Urol; 1989 Feb; 141(2):337-40. PubMed ID: 2643726
[TBL] [Abstract][Full Text] [Related]
3. S phase fraction of human bladder tumor measured in situ with bromodeoxyuridine labeling.
Nemoto R; Uchida K; Hattori K; Shimazui T; Nishijima Y; Saito S; Koiso K; Harada M
J Urol; 1988 Feb; 139(2):286-9. PubMed ID: 3276925
[TBL] [Abstract][Full Text] [Related]
4. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Davis RL
Cancer; 1986 Oct; 58(7):1466-72. PubMed ID: 2427189
[TBL] [Abstract][Full Text] [Related]
5. Estimations of the S phase fraction in situ in transitional cell carcinoma of the renal pelvis and ureter with bromodeoxyuridine labelling.
Nemoto R; Hattori K; Sasaki A; Miyanaga N; Koiso K; Harada M
Br J Urol; 1989 Oct; 64(4):339-44. PubMed ID: 2819383
[TBL] [Abstract][Full Text] [Related]
6. The proliferative activity of neurilemomas.
Lee KS; Nagashima T; Cho KG; Mampalam TJ; Pitts LH; Hoshino T
Surg Neurol; 1989 Dec; 32(6):427-33. PubMed ID: 2700052
[TBL] [Abstract][Full Text] [Related]
7. Estimation of growth fraction in situ in human bladder cancer with bromodeoxyuridine labelling.
Nemoto R; Hattori K; Uchida K; Shimazui T; Koiso K; Harada M
Br J Urol; 1990 Jan; 65(1):27-31. PubMed ID: 2310929
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA)/cyclin in human prostate adenocarcinoma.
Nemoto R; Kawamura H; Miyakawa I; Uchida K; Hattori K; Koiso K; Harada M
J Urol; 1993 Jan; 149(1):165-9. PubMed ID: 8093265
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression.
Carroll PR; Waldman FM; Rosenau W; Cohen MB; Vapnek JM; Fong P; Narayan P; Mayall BH
J Urol; 1993 Feb; 149(2):403-7. PubMed ID: 8093910
[TBL] [Abstract][Full Text] [Related]
10. The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
Nagashima T; Hoshino T; Cho KG; Edwards MS; Hudgins RJ; Davis RL
Cancer; 1988 Jun; 61(12):2433-8. PubMed ID: 3284636
[TBL] [Abstract][Full Text] [Related]
11. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
[TBL] [Abstract][Full Text] [Related]
12. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
Zhao J; Epstein JI
Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
[TBL] [Abstract][Full Text] [Related]
13. [A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
Nagashima T; Hoshino T
No To Shinkei; 1985 Dec; 37(12):1195-201. PubMed ID: 3912000
[TBL] [Abstract][Full Text] [Related]
14. In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Lee SS; Lee TS; Park JS; Cho EK; Chung CH
J Korean Med Sci; 1989 Dec; 4(4):193-201. PubMed ID: 2639694
[TBL] [Abstract][Full Text] [Related]
15. Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma.
Meyer JS; Koehm SL; Hughes JM; Higa E; Wittliff JL; Lagos JA; Manes JL
Cancer; 1993 Jun; 71(11):3531-40. PubMed ID: 8490901
[TBL] [Abstract][Full Text] [Related]
16. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical detection of S-phase cells in normal and neoplastic cervical epithelium by anti-BrdU monoclonal antibody.
Fukuda K; Iwasaka T; Hachisuga T; Sugimori H; Tsugitomi H; Mutoh F
Anal Quant Cytol Histol; 1990 Apr; 12(2):135-8. PubMed ID: 2350389
[TBL] [Abstract][Full Text] [Related]
18. [Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the analysis of tumor cell kinetics by flow cytometry].
Kanno M; Takeda Y; Nakamura S
Nihon Rinsho; 1992 Oct; 50(10):2333-7. PubMed ID: 1280304
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle parameters and DNA ploidy in colorectal carcinomas.
Yousuf N; Khan S; Sheikh Y; Hyams D; Bokhari J; Raza A
J Surg Res; 1991 Dec; 51(6):457-62. PubMed ID: 1943081
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle analysis in the rat external granular layer evaluated by several bromodeoxyuridine immunoperoxidase staining protocols.
Molina V; Rodríguez-Vázquez L; Owen D; Valero O; Martí J
Histochem Cell Biol; 2017 Nov; 148(5):477-488. PubMed ID: 28681271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
